SABBY GALE 13G 01.02.13

Company

SELLAS Life Sciences Group, Inc.

Filed

January 2, 2013

Accession Number

0001535610-13-000001

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →